Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

Sanofi reception

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

French pharma firm offers $105 apiece for the spin-out’s shares

Biogen Idec building

NICE finally starts review of Biogen’s Spinraza for SMA

Will evaluate the treatment based on its Single Technology Appraisal process

Digital Pharma Advances London 2018

Digital Pharma Advances 2018: Attend our presentation in London

We are very excited to be attending and speaking at The Digital Pharma Advances Conference, held January 30th in London.

Anthill Agency

- PMLiVE

Targovax appoints Michael Bogenstaetter as chief business officer

He joins the immuno-oncology biotech from Interim Assignments

Hikma appoints group scientific officer and global head of R&D

Dr Surendera Tyagi joins the pharma group from Fresenius Kabi

Integrating digital biomarkers into precision medicine

Leveraging digital technologies to enhance the clinical evaluation and delivery of precision therapies

Can Cinderella save us?

AMR research ‘under threat’ due to lack of economic incentives

But industry report also shows progress made by the private sector

- PMLiVE

MHRA: No change for pre-Brexit products after UK exits the EU

And UK plans to follow EU rules for an implementation period after March 2019

Novartis day

Novartis doubles down on biosimilars with Biocon alliance

The companies will develop multiple immunology and oncology biosimilars

- PMLiVE

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

The bone marrow cancer therapy is now temporarily approved as a fourth-line treatment

- PMLiVE

Richard Paulson joins Ipsen as CEO for North America

He also becomes an executive vice-president at the French biopharma

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links